CTI BioPharma Corp. Cash and Cash Equivalents 2011-2026 | CTIC

Annual Cash and Cash Equivalents CTI BioPharma Corp.

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
30.4 M	65.4 M	40.4 M	31.1 M	36.4 M	27.2 M	44 M	128 M	70.9 M	71.6 M	50.4 M	47.1 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
128 M	27.2 M	53.6 M

Quarterly Cash and Cash Equivalents CTI BioPharma Corp.

2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
24.2 M	30.4 M	32 M	66.1 M	96.9 M	65.4 M	95.3 M	71.9 M	33.1 M	40.4 M	40.4 M	40.4 M	40.4 M	31.1 M	31.1 M	31.1 M	31.1 M	36.4 M	36.4 M	36.4 M	36.4 M	43.2 M	27.2 M	27.2 M	27.2 M	44 M	44 M	44 M	44 M	128 M	128 M	128 M	128 M	70.9 M	70.9 M	70.9 M	70.9 M	71.6 M	71.6 M	71.6 M	71.6 M	50.4 M	50.4 M	50.4 M	50.4 M	47.1 M	47.1 M	47.1 M	47.1 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
128 M	24.2 M	55.5 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
AgeX Therapeutics AGE	345 K	-	-10.17 %	$ 12.2 K	USA
Autolus Therapeutics plc AUTL	240 M	$ 1.37	-8.67 %	$ 350 M	Britain
Aeglea BioTherapeutics AGLE	89.4 M	-	-	$ 1.01 B	USA
Adagene ADAG	75.2 M	$ 1.65	6.11 %	$ 92.9 M	China
Alterity Therapeutics Limited ATHE	34.8 M	$ 3.43	-2.69 %	$ 8.25 B	Australia
Biogen BIIB	2.38 B	$ 177.93	-4.15 %	$ 25.9 B	USA
Arrowhead Pharmaceuticals ARWR	227 M	$ 65.89	-0.06 %	$ 8.81 B	USA
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
Akero Therapeutics AKRO	340 M	-	-	$ 3.67 B	USA
AVROBIO AVRO	98 M	-	1083.1 %	$ 745 M	USA
Midatech Pharma plc MTP	1.67 M	-	-18.52 %	$ 27.3 M	Britain
AstraZeneca PLC AZN	5.49 B	$ 94.4	0.82 %	$ 96.9 B	Britain
BeiGene, Ltd. BGNE	2.63 B	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	21.8 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	86.5 M	-	-7.31 %	$ 87 M	USA
Ascendis Pharma A/S ASND	560 M	$ 214.55	2.77 %	$ 5 B	Danmark
Codiak BioSciences CDAK	76.9 M	-	-55.98 %	$ 2.15 M	USA
ARCA biopharma ABIO	61.6 M	-	1052.0 %	$ 415 M	USA
Bristol-Myers Squibb Company BMY	10.3 B	$ 55.84	0.13 %	$ 113 B	USA
Cerevel Therapeutics Holdings CERE	416 M	-	-	$ 7.29 B	USA
Acasti Pharma ACST	22.1 M	-	4.01 %	$ 150 M	Canada
Caladrius Biosciences CLBS	16.2 M	-	-16.75 %	$ 25.8 M	USA
BioLineRx Ltd. BLRX	10.4 M	$ 2.86	-	$ 908 M	Israel
Clearside Biomedical CLSD	28.9 M	-	-	$ 25.3 M	USA
Chimerix CMRX	27.7 M	-	-	$ 756 M	USA
Adaptimmune Therapeutics plc ADAP	144 M	-	-15.15 %	$ 60.3 M	Britain
BioNTech SE BNTX	9.76 B	$ 106.88	4.6 %	$ 27.2 B	Germany
Can-Fite BioPharma Ltd. CANF	8.27 M	$ 4.18	-1.65 %	$ 9.1 B	Israel
AIkido Pharma AIKI	4.08 M	-	1.93 %	$ 17.4 M	USA
Catalyst Biosciences CBIO	33.5 M	$ 11.09	1.0 %	$ 730 M	USA
Albireo Pharma ALBO	248 M	-	-0.23 %	$ 916 M	USA
CureVac N.V. CVAC	811 M	-	-	$ 867 M	Germany
Acer Therapeutics ACER	2.33 M	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	13.4 M	-	-	$ 2.17 B	USA
AlloVir ALVR	118 M	-	4.14 %	$ 49.1 M	USA
Ayala Pharmaceuticals AYLA	2.41 M	-	-	$ 7.46 M	Israel
Coherus BioSciences CHRS	103 M	$ 1.69	2.12 %	$ 159 M	USA
Ampio Pharmaceuticals AMPE	4.09 M	-	-11.43 %	$ 502 K	USA
Amphastar Pharmaceuticals AMPH	152 M	$ 28.99	-1.39 %	$ 1.4 B	USA
Celldex Therapeutics CLDX	28.4 M	$ 25.71	0.16 %	$ 1.66 M	USA
Cellectis S.A. CLLS	143 M	$ 4.24	-0.47 %	$ 116 M	France
Acorda Therapeutics ACOR	30 M	-	-24.86 %	$ 820 K	USA
Applied Molecular Transport AMTI	61.1 M	-	-	$ 10.1 M	USA
Brickell Biotech BBI	10.9 M	-	-5.38 %	$ 6.06 M	USA
Burford Capital Limited BUR	322 M	$ 9.57	-0.78 %	$ 1.55 B	Britain